Description
ProteoGenix’s AI-Powered Affinity Maturation service spices up your monoclonal antibodies via machine learning and in silico tools to enhance both affinity and specificity faster than ever. In just two weeks, you’ll get epitope/paratope mapping, followed by iterative AI-driven cycles of variant design and experimental validation. The process is designed for reliability, using the in-house XtenCHO™ Race platform for expression and assays like Biacore and ELISA for confirmation. You retain full IP ownership of all improved variants.